title: [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
abstract: An 82-year-old female presented with a tumor in the right-frontal region and was diagnosed as MHE, based on the clinical and pathological findings. Increased LAK (lymphokine-activated killer cell) activity was observed during treatment with intraarterial continuous infusion of rIL-2. In addition, the decrease in tumor size was started when LAK activity became high. Treatments for MHE and mechanism of these therapies were discussed using data from this case and other authors' reports.
authors.affiliation: Dept. of Dermatology, Kitasato University School of Medicine.
authors.forename: A
authors.initials: A
authors.lastname: Fujioka
authors.forename: M
authors.initials: M
authors.lastname: Sugitani
authors.forename: Z
authors.initials: Z
authors.lastname: Suzuki
authors.forename: J
authors.initials: J
authors.lastname: Tokita
authors.forename: K
authors.initials: K
authors.lastname: Yorimitsu
authors.forename: Y
authors.initials: Y
authors.lastname: Sezai
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006258:Head and Neck Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D006390:Hemangioendothelioma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007376:Interleukin-2 / Q000008:administration & dosage*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D011994:Recombinant Proteins / Q000008:administration & dosage
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins